学术会议:紧随研究趋势 洞察学术热点 进入>
产业会议:新技术,新领域,深入产业环节 进入>
举办会议及论坛超过百场 邀请海内外院士超过50名 教授PI专家授课超过1000名 总参会人数超过10万人
2017-09-21至2017-09-22 中国 杭州
Menu
报名参会
Sign up

拟邀嘉宾Prepare Guest

周新华 总裁

嘉和生物

周新华 总裁

嘉和生物

个人简介:Dr. Joe X Zhou, CEO of GenorBioPharma Co.Ltd.,Walvax Group. Dr. Joe Zhou is the CEO of Genor Biopharma Co. Ltd. Vice President and R&D Head of Walvax Group. He also is a visiting professor teaching Master’s Degree Program in International Pharmaceutical Engineering Management (IPEM)at Peking University, China. He is an invited vice-chair of Biopharmaceuticals Committee under China Pharmaceuticals Society, the Founder and first Chair of China Protein Drug Quality Alliance (CPDQA), the first Chair of Biological Drug Product and Process Committee of China ISPE, and the Chair of Amgen Aluminums Association (AAA) in China. Under his guidance, Genor Biopharma has 3 mAbbiosimilars in Phase 3 clinical studies and 2 novel mAb (including PD-1 antibody) in Phase 1 studies. This company filed 10 IND in total in past 9 years.

Previously, Dr. Zhou was Scientific Director at Amgen, Thousand Oaks, USA. His over 20-years’ experience of process development, multiple project management capacity in cGMP and non-GMP reproducible purification/production of protein/antibody therapeutics from FIH to CPD with depth knowledge of CHO clone selection, cell culture optimization, real time analytical assays, formulation and product specification for drug substances and drug products made Dr. Zhou many times as Project Process Team Leader/Project Team Leader/Cross Functional Core Investigation Teams Leaders at Amgen in the past. 


邀请函

下载邀请函

赞助企业

大会咨询
姓名 *

E-mail*

电话: *

消息: *

×
留下姓名电话和邮箱,邀请函直接发送到邮箱
*姓名:
* 电话:
* Email: